Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 3.669
Filtrar
3.
Wien Klin Wochenschr ; 136(9-10): 305-308, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38717481
4.
J Virol ; 98(5): e0054924, 2024 May 14.
Artículo en Inglés | MEDLINE | ID: mdl-38624241

RESUMEN

As an Argentine scientist, the defunding of CONICET and INTA feels like a blow to progress and our future. Despite free education, these cuts force talented researchers to seek opportunities abroad. Argentina's history of scientific achievement, from Nobel Prizes to COVID-19 vaccines, is at risk. Defunding science weakens our ability to solve problems and compete globally.


Asunto(s)
COVID-19 , Argentina , Humanos , COVID-19/epidemiología , COVID-19/prevención & control , SARS-CoV-2 , Vacunas contra la COVID-19/inmunología , Historia del Siglo XX , Historia del Siglo XXI , Premio Nobel , Investigación Biomédica/historia
11.
Mult Scler ; 30(6): 623-629, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38523325

RESUMEN

Torben Fog was committed to multiple sclerosis (MS) research for more than four decades, starting before the defence of his thesis in 1948 and lasting until his death in 1987. His research was multi-facetted, making him one of the great pioneers in the study of essential parts of the pathology, immunology and treatment of MS. He has contributed with meticulous studies of the MS plaques, documenting the perivenous distribution of plaques in the spinal cord. He constructed a scoring system for the disability in MS and used a computer programme to calculate a total neurological deficit. Together with his co-workers, Fog in 1972 was the first to report the association between MS and the human leukocyte antigen system. Fog can be considered as the father of immunomodulatory therapy in MS, treating MS patients with the first transfer factor, and as early as 1980, he was the first to treat MS with intramuscular natural interferon.


Asunto(s)
Esclerosis Múltiple , Esclerosis Múltiple/historia , Historia del Siglo XX , Humanos , Dinamarca , Investigación Biomédica/historia
12.
J Am Geriatr Soc ; 72(5): 1574-1582, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38445895

RESUMEN

The National Institute on Aging (NIA), part of the National Institutes of Health (NIH), was founded in 1974 to support and conduct research on aging and the health and well-being of older adults. Fifty years ago, the concept of studying aging generated much skepticism. Early NIA-funded research findings helped establish the great value of aging research and provided the foundation for significant science advances that have improved our understanding of the aging process, diseases and conditions associated with aging, and the effects of health inequities, as well as the need to promote healthy aging lifestyles. Today, we celebrate the many important contributions to aging research made possible by NIA, as well as opportunities to continue to make meaningful progress. NIA emphasizes that the broad aging research community must continue to increase and expand our collective efforts to recruit and train a diverse next generation of aging researchers.


Asunto(s)
Envejecimiento , Aniversarios y Eventos Especiales , Investigación Biomédica , National Institute on Aging (U.S.) , Humanos , Estados Unidos , Anciano , Envejecimiento/fisiología , Investigación Biomédica/historia , Historia del Siglo XX , Historia del Siglo XXI , Envejecimiento Saludable , Geriatría/historia
13.
Cell ; 187(6): 1343-1346, 2024 Mar 14.
Artículo en Inglés | MEDLINE | ID: mdl-38490176

RESUMEN

The history of sex research demonstrates an ongoing coexistence of multiple, conflicting meanings of sex. This history raises questions for scientists about the deployment of a research variable that lacks precision. Cross-disciplinary collaboration between scientists and science and technology studies (STS) scholars offers a way to find solutions to this problem.


Asunto(s)
Investigación Biomédica , Sexo , Tecnología , Investigación Biomédica/historia
18.
Transplantation ; 108(5): 1189-1199, 2024 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-38196091

RESUMEN

BACKGROUND: Groundbreaking biomedical research has transformed renal transplantation (RT) into a widespread clinical procedure that represents the mainstay of treatment for end-stage kidney failure today. Here, we aimed to provide a comprehensive bibliometric perspective on the last half-century of innovation in clinical RT. METHODS: The Web of Science Core Collection was used for a comprehensive screening yielding 123 303 research items during a 50-y period (January 1973-October 2022). The final data set of the 200 most-cited articles was selected on the basis of a citation-based strategy aiming to minimize bias. RESULTS: Studies on clinical and immunological outcomes (n = 63 and 48), registry-based epi research (n = 38), and randomized controlled trials (n = 35) dominated the data set. Lead US authors have signed 110 of 200 articles. The overall level of evidence was high, with 84% of level1 and -2 reports. Highest numbers of these articles were published in New England Journal of Medicine , Transplantation , and American Journal of Transplantation. Increasing trend was observed in the number of female authors in the postmillennial era (26% versus 7%). CONCLUSIONS: This study highlights important trends in RT research of the past half-century. This bibliometric perspective identifies the most intensively researched areas and shift of research interests over time; however, it also describes important imbalances in distribution of academic prolificacy based on topic, geographical aspects, and gender.


Asunto(s)
Bibliometría , Investigación Biomédica , Trasplante de Riñón , Humanos , Trasplante de Riñón/tendencias , Investigación Biomédica/tendencias , Investigación Biomédica/historia , Fallo Renal Crónico/cirugía , Historia del Siglo XX , Publicaciones Periódicas como Asunto/tendencias , Historia del Siglo XXI , Difusión de Innovaciones
20.
JAMA ; 330(15): 1423-1424, 2023 10 17.
Artículo en Inglés | MEDLINE | ID: mdl-37732817

RESUMEN

In this Viewpoint, Lasker Award winner Piet Borst looks back over a 50-year career in scientific research, including work with trypanosomatids, mechanisms of drug resistance in cancer cells, and inborn errors of metabolism.


Asunto(s)
Distinciones y Premios , Investigación Biomédica , Animales , Humanos , Investigación Biomédica/historia , Historia del Siglo XX , Historia del Siglo XXI , Medicina , Errores Innatos del Metabolismo , Neoplasias/terapia , Países Bajos , Parásitos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...